AUROBINDO FINASTERIDE finasteride 1 mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

finasteride, Quantity: 1 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Finasteride

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; docusate sodium; pregelatinised maize starch; sodium starch glycollate type A; titanium dioxide; hypromellose; hyprolose; purified talc; iron oxide yellow; iron oxide red

Mode d'administration:

Oral

Unités en paquet:

28, 30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

AUROBINDO FINASTERIDE is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. AUROBINDO FINASTERIDE is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.

Descriptif du produit:

Visual Identification: Brown colored, film coated, biconvex, octagonal shaped tablets, debossed with 'J' on side and '81' on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-04-30